Sagarika Bose
About Sagarika Bose
Sagarika Bose serves as the Senior Director of Drug Product Development and CMC at Roivant Sciences in New York. With extensive experience in the pharmaceutical industry, she has held various roles at notable companies and has a strong academic background in Pharmaceutical Technology.
Current Role at Roivant Sciences
Sagarika Bose serves as the Senior Director of Drug Product Development and CMC at Roivant Sciences. She has held this position since 2021, contributing her expertise in drug development strategies and regulatory compliance. Based in New York, she oversees the formulation and process development for various drug products, ensuring alignment with industry standards and regulatory requirements.
Previous Experience in Pharmaceutical Industry
Before joining Roivant Sciences, Sagarika Bose worked at Merck as Global CMC and Clinical from 2019 to 2021. Her earlier roles include Principal Scientist at Endo Pharmaceuticals from 2010 to 2013, and Senior Manager at Terumo from 2014 to 2019. She also held positions at Amarin Corporation as Director and at Pfizer in various research roles. Her extensive experience spans over two decades in the pharmaceutical industry.
Educational Background
Sagarika Bose has a strong educational foundation in pharmaceutical sciences. She earned her Doctor of Philosophy (Ph.D.) in Pharmaceutical Technology from the University of Connecticut. She also holds a Master of Science (MS) in Pharmaceutical Science from Auburn University and a Bachelor's Degree in Pharmaceutical Engineering and Technology from Jadavpur University. Her education has equipped her with the knowledge necessary for her roles in drug development.
Expertise in Drug Development and Regulatory Affairs
Sagarika Bose has proven experience in executing formulation and process development strategies, including the application of Quality by Design (QbD) and Process Analytical Technology (PAT). She has extensive knowledge in managing global teams and has contributed to various regulatory submissions, including IND, NDA, sNDA, and 505(b)(2) filings. Her expertise also includes technical writing for the Chemistry, Manufacturing, and Controls (CMC) section.
Publications and Patents
Sagarika Bose is a lead author of numerous technical reports, stability studies, regulatory documents, and book chapters. She holds several patents related to drug delivery systems and formulation techniques. Her contributions to the field of pharmaceutical sciences reflect her commitment to advancing drug development processes and improving therapeutic outcomes.